rss
Emerg Med J 2001;18:120-122 doi:10.1136/emj.18.2.120
  • Best evidence topic report

SimpliRed and diagnosis of deep venous thrombosis

  1. Steve Jones,
  2. Magnus Harrison
  1. Department of Emergency Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M139WL, UK

      Report by Steve Jones, Clinical Research Fellow Search checked by Magnus Harrison, Clinical Research Fellow

      Clinical scenario

      A patient attends the emergency department with signs and symptoms consistent with a deep venous thrombosis. Somebody suggests that there is a new bedside blood test, called SimpliRed, that may help to rule out the diagnosis in your patient. You know that ruling out a diagnosis is possible by having a test with a high sensitivity or negative predictive value. You wonder what evidence there is to suggest that SimpliRed fulfils these criteria?

      Three part question

      In a [patient with a suspected DVT] does the [SimpliRed test] reliably [rule out the diagnosis]?

      Search strategy

      Medline 1966–11/00 using the OVID interface. [(exp thrombosis or exp venous thrombosis or thrombosis.mp OR venous thrombosis.mp deep venous thrombosis.mp) AND (exp fibrin fibrinogen degradation products or simplired.mp OR d-dimer$.mp)] LIMIT to human and english language OR Medline 1966–11/00 using the OVID interface. simplired.mp.

      Search outcome

      Altogether 741 and 37 papers found of which 13 were relevant and of sufficient quality. These 13 remaining papers are shown in table 6.

      Table 6

      Comments

      The “gold standard” investigation for DVT is contrast venography. This has now been replaced in many centres with a strategy of single or serial compression ultrasound, hence the use of different reference standard tests.

      If an investigation is to be used in order to rule out a diagnosis, then it must have a sensitivity of 95% or above. In some of the studies mentioned this is the case, however such is the variability of the results obtained in the other studies the safety of SimpliRed as a lone exclusionary test must be in question. The reasons for this variability may include the operators of the assay or the various techniques used. Many of the results however are still inadequate.

      Clinical bottom line

      It is not safe to use SimpliRed as a lone exclusionary test for a patient presenting to the emergency department with a possible DVT.

      Report by Steve Jones, Clinical Research Fellow Search checked by Magnus Harrison, Clinical Research Fellow

      References

      This Article

      Services

      1. Request permissions

      Responses

      1. Submit a response
      2. No responses published

      Social bookmarking

      Register for free content


      Free sample
      This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EMJ.
      View free sample issue >>

      Free archive
      The full back archive is now available for EMJ. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.